T-cell infusion
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for T-cell infusion, covering 2017-03-15 to 2024-11-07. Get the full timeline:
Most recent: Clinical Trial Update: T-Cell Infusion, Aldesleukin, and Utomilumab in Treating Patients With Recurrent Ovarian Cancer [Phase 1, Phase 2]